E157-2130 Screening compound: N-(5-{[4-(4-fluorophenyl)piperazin-1-yl]sulfonyl}-1,3,4-thiadiazol-2-yl)benzamide

E157-2130 Screening compound: N-(5-{[4-(4-fluorophenyl)piperazin-1-yl]sulfonyl}-1,3,4-thiadiazol-2-yl)benzamide
E157-2130 Screening compound: N-(5-{[4-(4-fluorophenyl)piperazin-1-yl]sulfonyl}-1,3,4-thiadiazol-2-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E157-2130
N-(5-{[4-(4-fluorophenyl)piperazin-1-yl]sulfonyl}-1,3,4-thiadiazol-2-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E157-2130

Molecular Formula

C19H18FN5O3S2 (C19 H18 FN5 O3 S2)

Compound Name

N-(5-{[4-(4-fluorophenyl)piperazin-1-yl]sulfonyl}-1,3,4-thiadiazol-2-yl)benzamide

IUPAC name

N-(5-{[4-(4-fluorophenyl)piperazin-1-yl]sulfonyl}-134-thiadiazol-2-yl)benzamide

SMILES

O=C(c1ccccc1)Nc(s1)nnc1S(N(CC1)CCN1c(cc1)ccc1F)(=O)=O

InChI

InChI=1S/C19H18FN5O3S2/c20-15-6-8-16(9-7-15)24-10-12-25(13-11-24)30(27,28)19-23-22-18(29-19)21-17(26)14-4-2-1-3-5-14/h1-9H,10-13H2,(H,21,22,26)

InChI Key

HJJQDEPXZWEYSL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14843594

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

447.51

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.460

Distribution Coefficient, logD

1.847

Water Solubility, LogSw

-3.71

Polar Surface Area

81.621

Acid Dissociation Constant (pKa)

5.80

Base Dissociation Constant (pKb)

5.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.10

E157-2130 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

Human Receptors Annotated Library (5376 compounds)

Purinergic Library (3321 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cardiovascular
  • Metabolic
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E157-2130 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E157-2130?
Check Price and Availability of E157-2130, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E157-2130 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E157-2130
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E157-2130
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E157-2130 available by request